Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||-2.92%||158.01||0.7%||$1349.36m|
|BMY||Bristol-Myers Squibb Co.||-1.35%||61.26||1.0%||$864.73m|
|MRK||Merck & Co., Inc.||-2.73%||72.58||0.7%||$812.99m|
|LLY||Eli Lilly & Co.||0.43%||204.69||1.1%||$785.50m|
|VYNE||VYNE Therapeutics, Inc.||-5.45%||7.46||0.0%||$94.74m|
|NVO||Novo Nordisk A/S||-1.47%||71.28||0.1%||$91.66m|
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.